tiprankstipranks
Trending News
More News >
MeVis Medical Solutions (GB:0HI7)
:0HI7
UK Market
Advertisement

MeVis Medical Solutions (0HI7) Ratios

Compare
0 Followers

MeVis Medical Solutions Ratios

GB:0HI7's free cash flow for Q2 2024 was €0.39. For the 2024 fiscal year, GB:0HI7's free cash flow was decreased by € and operating cash flow was €0.26. See a summary of the company’s cash flow.
Ratios
TTM
Sep 24Sep 23Sep 22Sep 21
Liquidity Ratios
Current Ratio
1.50 1.66 1.50 1.63 1.48
Quick Ratio
1.50 1.66 1.49 1.62 1.47
Cash Ratio
1.03 1.13 0.96 1.15 0.53
Solvency Ratio
0.31 0.49 0.59 0.48 0.59
Operating Cash Flow Ratio
0.00 0.85 0.50 1.37 0.39
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
€ 890.18K€ 1.14M€ 1.13M€ 1.17M€ 1.09M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.49 1.57 1.75 1.54 1.56
Debt Service Coverage Ratio
0.00 118.12 2.05K 488.87 501.64
Interest Coverage Ratio
0.00 150.47 2.05K 485.12 495.07
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.00 0.02 <0.01 <0.01 <0.01
Net Debt to EBITDA
-2.78 -1.50 -1.17 -1.42 -0.66
Profitability Margins
Gross Profit Margin
39.33%40.38%96.02%97.31%96.34%
EBIT Margin
26.25%29.27%42.00%28.63%33.89%
EBITDA Margin
26.80%29.83%42.48%33.15%34.87%
Operating Profit Margin
31.31%37.16%42.00%32.38%33.89%
Pretax Profit Margin
31.18%29.03%41.98%28.56%33.82%
Net Profit Margin
30.33%28.37%41.52%28.04%33.30%
Continuous Operations Profit Margin
30.33%28.37%41.52%28.04%33.30%
Net Income Per EBT
97.29%97.73%98.89%98.16%98.44%
EBT Per EBIT
99.56%78.12%99.95%88.21%99.80%
Return on Assets (ROA)
10.05%17.54%24.96%16.51%20.52%
Return on Equity (ROE)
14.93%27.60%43.69%25.50%32.00%
Return on Capital Employed (ROCE)
13.65%30.39%36.60%25.14%28.58%
Return on Invested Capital (ROIC)
13.35%29.70%36.20%24.68%28.13%
Return on Tangible Assets
10.05%17.54%24.96%16.51%20.53%
Earnings Yield
5.90%9.52%12.51%7.66%9.86%
Efficiency Ratios
Receivables Turnover
3.17 6.54 4.68 7.14 6.24
Payables Turnover
62.26 134.73 3.88 1.82 6.75
Inventory Turnover
0.00 0.00 5.59 4.36 12.96
Fixed Asset Turnover
27.83 118.73 115.80 133.13 88.14
Asset Turnover
0.33 0.62 0.60 0.59 0.62
Working Capital Turnover Ratio
2.55 3.71 4.15 4.16 4.80
Cash Conversion Cycle
109.16 53.11 49.06 -65.46 32.64
Days of Sales Outstanding
115.02 55.81 77.96 51.14 58.53
Days of Inventory Outstanding
0.00 0.00 65.24 83.72 28.17
Days of Payables Outstanding
5.86 2.71 94.15 200.32 54.06
Operating Cycle
115.02 55.81 143.20 134.87 86.70
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 3.22 2.67 5.02 1.59
Free Cash Flow Per Share
0.00 3.17 2.60 4.99 1.53
CapEx Per Share
0.00 0.04 0.07 0.03 0.06
Free Cash Flow to Operating Cash Flow
0.00 0.99 0.97 0.99 0.96
Dividend Paid and CapEx Coverage Ratio
0.00 0.74 1.04 1.59 1.73
Capital Expenditure Coverage Ratio
0.00 73.44 36.49 179.53 28.18
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
0.00 0.34 0.26 0.56 0.17
Free Cash Flow Yield
0.00%11.17%7.59%15.30%4.82%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.96 10.51 7.99 13.05 10.15
Price-to-Sales (P/S) Ratio
5.14 2.98 3.32 3.66 3.38
Price-to-Book (P/B) Ratio
2.53 2.90 3.49 3.33 3.25
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 8.95 13.18 6.53 20.76
Price-to-Operating Cash Flow Ratio
0.00 8.83 12.81 6.50 20.03
Price-to-Earnings Growth (PEG) Ratio
2.16 -0.28 0.11 -0.65 -0.35
Price-to-Fair Value
2.53 2.90 3.49 3.33 3.25
Enterprise Value Multiple
16.42 8.50 6.64 9.62 9.03
Enterprise Value
38.61M 43.94M 52.92M 51.71M 53.92M
EV to EBITDA
16.42 8.50 6.64 9.62 9.03
EV to Sales
4.40 2.53 2.82 3.19 3.15
EV to Free Cash Flow
0.00 7.61 11.20 5.69 19.35
EV to Operating Cash Flow
0.00 7.51 10.90 5.66 18.66
Tangible Book Value Per Share
9.79 9.79 9.79 9.79 9.79
Shareholders’ Equity Per Share
9.79 9.79 9.79 9.79 9.79
Tax and Other Ratios
Effective Tax Rate
0.03 0.02 0.01 0.02 0.02
Revenue Per Share
4.82 9.53 10.31 8.91 9.41
Net Income Per Share
1.46 2.70 4.28 2.50 3.13
Tax Burden
0.97 0.98 0.99 0.98 0.98
Interest Burden
1.19 0.99 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.03 0.02 0.05 0.04
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 1.19 0.62 2.01 0.51
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis